Tech Company Financing Transactions
SARCode Bioscience Funding Round
On 12/31/2006, SARCode Bioscience received $25 million in investment from Clarus.
Transaction Overview
Company Name
Announced On
12/31/2006
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Clarus (Dennis Henner)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1000 Marina Boulevard 250
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Website
Email Address
Overview
SARcode is a private company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Quinton Oswald
Chief Financial Officer
Todd Creech
Chief Medical Officer
Charles Semba
VP - Manufacturing
Lane Welton
VP - Regulatory Affairs
Mary Newman
Browse more venture capital transactions:
Prev: 12/31/2006: Buzznet venture capital transaction
Next: 12/31/2006: AscendHealth venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs